Ontology highlight
ABSTRACT:
SUBMITTER: Lee WT
PROVIDER: S-EPMC7665673 | biostudies-literature | 2020 Oct
REPOSITORIES: biostudies-literature
The Journal of infectious diseases 20210101 1
Passive transfer of antibodies from COVID-19 convalescent patients is being used as an experimental treatment for eligible patients with SARS-CoV-2 infections. The United States Food and Drug Administration's (FDA) guidelines for convalescent plasma initially recommended target antibody titers of 160. We evaluated SARS-CoV-2 neutralizing antibodies in sera from recovered COVID-19 patients using plaque reduction neutralization tests (PRNT) at moderate (PRNT50) and high (PRNT90) stringency thresho ...[more]